729 related articles for article (PubMed ID: 28944281)
1. Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
Lee CS; Bishop ES; Zhang R; Yu X; Farina EM; Yan S; Zhao C; Zheng Z; Shu Y; Wu X; Lei J; Li Y; Zhang W; Yang C; Wu K; Wu Y; Ho S; Athiviraham A; Lee MJ; Wolf JM; Reid RR; He TC
Genes Dis; 2017 Jun; 4(2):43-63. PubMed ID: 28944281
[TBL] [Abstract][Full Text] [Related]
2. Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.
Scarsella L; Ehrke-Schulz E; Paulussen M; Thal SC; Ehrhardt A; Aydin M
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543743
[TBL] [Abstract][Full Text] [Related]
3. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral vector-mediated gene transfer for human gene therapy.
Breyer B; Jiang W; Cheng H; Zhou L; Paul R; Feng T; He TC
Curr Gene Ther; 2001 Jul; 1(2):149-62. PubMed ID: 12108952
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus as a Vector and Oncolytic Virus.
Matsunaga W; Gotoh A
Curr Issues Mol Biol; 2023 Jun; 45(6):4826-4840. PubMed ID: 37367056
[TBL] [Abstract][Full Text] [Related]
6. Improvements in gene therapy: averting the immune response to adenoviral vectors.
Ritter T; Lehmann M; Volk HD
BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
[TBL] [Abstract][Full Text] [Related]
7. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
[TBL] [Abstract][Full Text] [Related]
9. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
10. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
11. Cancer gene therapy by adenovirus-mediated gene transfer.
Wu Q; Moyana T; Xiang J
Curr Gene Ther; 2001 May; 1(1):101-22. PubMed ID: 12109134
[TBL] [Abstract][Full Text] [Related]
12. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
[TBL] [Abstract][Full Text] [Related]
13. A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection.
Boddin J; Ip WH; Wilkens B; von Stromberg K; Ching W; Koyuncu E; Bertzbach LD; Dobner T
mBio; 2022 Apr; 13(2):e0014422. PubMed ID: 35254132
[TBL] [Abstract][Full Text] [Related]
14. Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy.
Tessarollo NG; Domingues ACM; Antunes F; Luz JCDSD; Rodrigues OA; Cerqueira OLD; Strauss BE
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919679
[TBL] [Abstract][Full Text] [Related]
15. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Biology Approaches for Engineering Next-Generation Adenoviral Gene Therapies.
Collins LT; Curiel DT
ACS Nano; 2021 Sep; 15(9):13970-13979. PubMed ID: 34415739
[TBL] [Abstract][Full Text] [Related]
17. Cancer gene therapy goes viral: viral vector platforms come of age.
Bezeljak U
Radiol Oncol; 2022 Feb; 56(1):1-13. PubMed ID: 35148469
[TBL] [Abstract][Full Text] [Related]
18. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
Joshi CR; Labhasetwar V; Ghorpade A
J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.
Jt S; M H; Wam B; Ac B; Sa N
J Mol Med (Berl); 2022 Jun; 100(6):875-901. PubMed ID: 35606652
[TBL] [Abstract][Full Text] [Related]
20. Viral gene therapy.
Mancheño-Corvo P; Martín-Duque P
Clin Transl Oncol; 2006 Dec; 8(12):858-67. PubMed ID: 17169759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
